Dr. Nicholas Weber, DO
Claim this profileK2 Medical Research
Studies Alzheimer's Disease
Studies Dementia
9 reported clinical trials
10 drugs studied
Area of expertise
1Alzheimer's Disease
ApoE positive
ApoE negative
2Dementia
Affiliated Hospitals
Clinical Trials Nicholas Weber, DO is currently running
Donanemab
for Alzheimer's Disease
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Recruiting1 award Phase 34 criteria
Brentuximab Vedotin
for Hodgkin Lymphoma
RADAR is a multicentre, international, randomised, open-label phase III clinical trial composed of 2 trials running in parallel. Trial 1 will be led and sponsored by University College London (UCL) and conducted in Europe and Australia/New Zealand. Trial 2 will be led by the Canadian Cancer Trials Group (CCTG) and conducted in North America, with CCTG the regulatory sponsor in Canada, and University of Miami the regulatory sponsor and IND holder in the US. Datasets from Trial 1 and Trial 2 will be combined to achieve the total sample size. Data analysis will be performed by UCL and therefore UCL is responsible for the clinicaltrials.gov entry. Eligible patients will be randomised to receive either ABVD or A2VD chemotherapy. An interim PET-CT scan will be performed after 2 cycles of treatment, which will be used to adapt subsequent treatment. Patients will receive a total of 3-4 cycles of chemotherapy and may also receive involved site radiotherapy as consolidation. Patients will be followed up for a minimum of 5 years after treatment.
Recruiting2 awards Phase 313 criteria
More about Nicholas Weber, DO
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Nicholas Weber, DO has experience with
- Placebo
- Donanemab
- LY3372993
- Aducanumab
- Brentuximab Vedotin
- Dacarbazine
Breakdown of trials Nicholas Weber, DO has run
Alzheimer's Disease
Dementia
Mild Cognitive Impairment
Healthy Subjects
Nervous System Disorders
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nicholas Weber, DO specialize in?
Nicholas Weber, DO focuses on Alzheimer's Disease and Dementia. In particular, much of their work with Alzheimer's Disease has involved ApoE positive patients, or patients who are ApoE negative.
Is Nicholas Weber, DO currently recruiting for clinical trials?
Yes, Nicholas Weber, DO is currently recruiting for 5 clinical trials in Ocoee Florida. If you're interested in participating, you should apply.
Are there any treatments that Nicholas Weber, DO has studied deeply?
Yes, Nicholas Weber, DO has studied treatments such as Placebo, Donanemab, LY3372993.
What is the best way to schedule an appointment with Nicholas Weber, DO?
Apply for one of the trials that Nicholas Weber, DO is conducting.
What is the office address of Nicholas Weber, DO?
The office of Nicholas Weber, DO is located at: K2 Medical Research, Ocoee, Florida 34761 United States. This is the address for their practice at the K2 Medical Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.